Search results

1. Professor James Brenton

   ... in resistance has been to develop novel phase II clinical trials with sequential collection and profiling of ovarian cancer tissues ...

2. Dr Massimiliano di Pietro

   ... recent multi-centre studies led by our group (TIME and ACE-B trials) have demonstrated that it is possible to increase diagnostic accuracy ...

3. Dr Michael Gattens

   ... am principal investigator for a number of national leukaemia trials, and coinvestigator for trials of new haemophilia factor concentrates in paediatric haemophilia ...

4. Dr Phil Jewsbury

   ... pre-clinical candidate drugs to proof-of-concept Phase 2 trials. Currently a Senior Project Director in AstraZeneca Oncology ...

5. Dr Richard Baird

   Early phase clinical trials, including expertise in: - first-in-human studies & drug combination trials - new small molecule & antibody therapeutics - development of ... cancer therapeutics. Investigator-initiated clinical trials funded by:  - Cancer Research UK  - EU HORIZON 2020 - AntiCancer ...

6. Professor Richard Gilbertson

   ... Program and founding Director of the Molecular Clinical Trials Core before being appointed as the Comprehensive Cancer Center Director, ...

7. Mr Richard Skells

   ... studies coordinated by CCTU and Cambridge Cancer Trials Centre. ...

8. Professor Robert Rintoul

   ... at Royal Papworth Hospital and Director of the Papworth Trials Unit Collaboration. He is co-lead of the CRUK Cambridge Centre Thoracic ... Rintoul’s research is focused around clinical trials, translational research and tissue banking in malignant mesothelioma and ...

9. Dr Robert Thomas

   ... completed and published a number of national research trials including; an evaluation of the impact of exercise in relation to ...

10. Dr Tim Mitchell

    ... CRT Pioneer Fund. This programme will start Phase 1 clinical trials at the Royal Marsden Hospital in June 2016. SKIL® (Sareum Kinase ...

11. Dr Alison Dunning

    ... association studies: BCAC http://bcac.ccge.medschl.cam.ac.uk, CIMBA http://apps.ccge.medschl.cam.ac.uk/consortia/cimba/ and PRACTICAL http://practical.ccge.medschl.cam.ac.uk as well as with the Radiogenomics Consortium (RGC ...

12. Dr Aisling Redmond

    ... the Royal College of Surgeons in Ireland and Cancer Research UK Cambridge Institute (with Professor Jason Carroll), partially funded by an ... Associate in Dr Duncan Odom’s lab at the Cancer Research UK Cambridge Institute, analysing non-coding regions of the genome. She is now ...

13. Professor Alan Warren

    Our long-term goal is to elucidate the molecular mechanisms of ribosome assembly in eukaryotic cells and to understand how defects in this process cause bone marrow failure and cancer predisposition. Assembly of the two subunits of the ribosome,...

14. Dr Annalisa Mupo

    Acute myeloid leukemia (AML) is a molecularly diverse malignancy representing 15-20% of all childhood and around 35% of all adult leukemias. My work aims to study commonly occurring mutations in AML-NK (normal karyotype) using sophisticated mouse models.

15. Mr Amit Roshan

    I am a CRUK / Royal College of Surgeons Clinician Scientist with a clinical interest in early stage melanoma. ...

16. Mr Angelos Kolias

    ... Hospital and University of Cambridge, Cambridge, UK. He also holds an adjunct Professorship at Humanitas University, Milan, ... Peter Hutchinson (Professor of Neurosurgery) and several UK and international collaborators, he has published impactful papers in ... a research network of neurosurgical trainees in the UK that has delivered several, high-quality, multicentre studies. ...

17. Dr Anna Piskorz

    ... Institute of Cancer Sciences University of Glasgow (UK). I’m also actively involved in Genomics England effort. ...

18. Mr Asif Jah

    ... Georges Medical College, Lucknow, India, he moved to the UK in 1998. He received surgical training at centres in Liverpool and London ... and one of the busiest tertiary HPB surgery centres in the UK. Besides performing major liver and pancreatic cancer surgery and liver ...

19. Professor Bertie Gottgens

    The Göttgens group uses a combination of experimental and computational approaches to study how transcription factor networks control the function of blood stem cells and how mutations that perturb such networks cause leukaemia. This integrated approach...

20. Professor Brian Huntly

    Our aim is to further characterise the molecular and cellular biology of cancer stem cells and to compare and contrast these to normal stem cells. To do so, we utilise malignant and normal haematopoiesis as our model system and use complementary genetic...

21. Dr Fazlur Rahman Talukdar

    I am spearheading a translational research initiative focused on developing circulating tumour DNA (ctDNA) based biomarkers derived from minimally invasive biospecimens, with the primary objective of early cancer detection and monitoring. I am a...

22. Dr Ramesh Bulusu

    ... the PAWS-GIST (paediatric, adolescent, wild type, syndromic Gastrointestinal stromal tumour) consortium. We offer a national service and ...

23. Professor Gillian Murphy

    ... These enzymes are located on both tumour and interacting stromal cells and are regulated by trafficking which allows specific ...

24. Dr Joo-Hyeon Lee

    ... cycling organ that is composed of diverse epithelial and stromal cell types, but has capacity to rapidly regenerate new cells after ...

25. Dr Luisa Pedro

    Studying the he cross-talk between tumour and its stromal microenvironment in order to choose the best targeting strategy to ...

26. Dr Adrien Hallou

    Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative approaches of biological systems during my MPhil and PhD in Biophysics at the University of Cambridge. I am now a...

27. Dr Andrew Gill

    I work in the hyperpolarized-13C imaging group in the Department of Radiology and apply computational methods to the analysis of MR images of tumours. I have in the past specialised in pharmacokinetic modelling of DCE-MRI data. My more recent work...

28. Professor Anthony Davenport

    Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology and in vivo imaging using positron emission...

29. Professor Tony Green

    ... Somatic mutations affecting this pathway occur in multiple tumour types and are especially common in human myeloproliferative neoplasms. ...

30. Dr Athena Matakidou

    ... models will allow in-vivo investigations of the underlying tumour biology and the discovery of new methodologies for the detection, ...

31. Dr Mariann Bienz

    ... cancers are due to inactivating mutations of the APC tumour suppressor, or to activating mutations in beta-catenin, a key effector ...

32. Professor Kevin Brindle

    ... responses to an anti-vascular drug and for detecting early tumour responses to immunotherapy. An early apoptotic response following ... spectroscopy (MRS) methods for the non-invasive detection of tumour cell death in vivo. ...

33. Dr Ashray Gunjur

    I am an early-career medical oncologist from Melbourne, Australia. I am broadly interested in immuno-oncology and the link between cancer and the gut microbiome, and am undertaking a PhD supervised by Dr David Adams and Dr Trevor Lawley (Wellcome...

34. Dr Cedric Ghevaert

    Cedric Gevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of...

35. Professor Christine Watson

    I am a mammary gland biologist with a particular interest in the signaling pathways that regulate mammary gland development and lineage commitment of progenitor cells. The mouse mammary gland is one of the most dramatic examples of physiologically...

36. Dr David Gilligan

    David Gilligan is a Consultant Clinical Oncologist at Addenbrooke's and Papworth Hospitals in Cambridge. He is the Clinical Lead for Acute Oncology at Addenbrooke's. He trained in pre clinical medicine at the University of Edinburgh and clinical...

37. Dr Elena Provenzano

    I am lead pathologist for several research projects in breast cancer. My primary interest is the translational aspect of clinical trials particularly in the neoadjuvant setting. Current trials include ARTemis, PARTNER, PRIMETIME and Neo-RT clinical...

38. Professor Ferdia Gallagher

    Dr Ferdia Gallagher studied medicine as an undergraduate at the University of Cambridge before completing his clinical studies at the University of Oxford. He trained as a radiologist at Addenbrooke?s Hospital in Cambridge. In 2005, he was awarded a...

39. Dr Fiona Harris

    Consultant Clinical Oncologist, Consultant in CNS tumours, TYA lead, CNS tumours in both the adult and teenage and young adult population

40. Mr Ray Hsu

    ... data that are enriched through linkage and consist of Cancer Registry data, Hospital Episode Statistics and Office of National Statistics ...

Pages